DEIRA LIMITED is a specialist pharmaceutical company focused on the manufacture and supply of Active Pharmaceutical Ingredients (APIs) used in the development of treatments for neurological and cognitive disorders, including Alzheimer’s disease, Parkinson’s disease, Bell’s Palsy, epilepsy, seizure disorders, and related conditions.

 

Originally established to provide clinical trial support, supply chain solutions, and commercial packaging services, the company has evolved into a trusted pharmaceutical partner offering packaging, storage, distribution, analytical testing, and regulatory support services to pharmaceutical organizations worldwide.